# Freeflow Ventures

Freeflow Ventures is a Venture Capital based in Berkeley, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Berkeley, United States
- **Region:** North America
- **Address:** 1314 Arch Street, Berkeley, CA, 94708, United States
- **Founded:** 2019
- **Assets under management:** $90M (per the firm, June 2024)
- **Website:** www.freeflow.io
- **LinkedIn:** https://www.linkedin.com/company/freeflow-ventures

## Regulatory record

- **CRD number:** 308194
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/308194

## About

Freeflow is a venture capital firm focused on advancing science to benefit humankind and our planet. | Freeflow is a venture capital firm focused on advancing science to benefit humankind and our planet. Our thesis is that science will unlock the transformations at scale that we need to survive and thrive. Our community of portfolio companies comes from Caltech and JPL where groundbreaking science research and deep tech innovation abound.

## Sectors

- AI/ML
- Digital Health
- Energy Transition & Renewables
- ClimateTech
- Robotics & Automation
- SpaceTech
- PropTech
- AgriTech & FoodTech
- WaterTech
- Advanced Manufacturing
- Biotech & Therapeutics

## People

- David Fleck — Founder & Managing Partner
- Kevin Barrett — Managing Partner
- Steve Roy — Operating Partner

## Questions

### Who leads investment decisions at Freeflow Ventures?

Founder David Fleck and Managing Partner Kevin Barrett set investment strategy and lead deal execution. Fleck brings early-stage venture and operating experience from Google and Disqus, while Barrett previously ran Altegra Health through a $900M+ exit to Change Healthcare. The firm also draws on a Scientific Advisory Board of Caltech and Berkeley professors to evaluate the underlying science.

### How does Freeflow source its deals, and does that produce proprietary flow?

Freeflow focuses almost exclusively on the research ecosystems of Caltech and UC Berkeley. The firm invests significant time — averaging 10 months — building relationships with founders before making a commitment, which it considers its primary sourcing moat. It does not claim proprietary flow in a legal sense, but its concentrated campus-level presence is designed to surface opportunities before they reach broader venture markets.

### What investment stages does Freeflow target, and does it do follow-on SPVs?

Freeflow invests from pre-seed through Series B, often as the first institutional investor. The firm actively uses SPVs for breakout portfolio companies, offering co-investment to its LP base as those companies scale. Its Fund One and Fund Two target early-stage exposure, while the 2024 Opportunity Fund was raised specifically to capture follow-on allocations.

### Is Freeflow restricted to life sciences, or does it invest in non-bio deep tech?

The firm splits its portfolio between human health and planetary health. Human health includes therapeutics, diagnostics, medical devices, drug discovery platforms, consumer health, and biomanufacturing. Planetary health spans carbon capture, energy storage, water treatment, geospatial data, automation, and advanced electronics. The common thread is deep tech that leverages AI, machine learning, and proprietary IP.

## Related profiles

- [Free Fenix](https://altss.com/profile/free-fenix)
- [Freeman Group](https://altss.com/profile/freeman-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/freeflow-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology